Panel: Risk-based strategies supporting development and supply of COVID vaccines

Panel: Risk-based strategies supporting development and supply of COVID vaccines

Tuesday, October 20, 2020 7:05 AM to 8:05 AM · 1 hr. (Africa/Abidjan)
Bioprocess & Manufacture

Information

 Moderator: Dr Cristiana Campa, Technical R&D Advisor, GSK Vaccines 

  

Mats Welin, Senior Expert Biotechnology, Medical Products Agency Läkemedelsverket, Sweden 

Dr Wim Van Molle, Quality assessor and vaccine release responsible, Sciensano, Belgium 

Diane Wilkinson, Senior Director, AstraZeneca 

Thierry Gastineau, Global Head Quality Advocacy, Culture and Innovation, Sanofi  

Session Type

Session Type
Panel

Log in